Cargando…
Sperm imprinting integrity in seminoma patients?
BACKGROUND: Testicular germ cell tumor such as seminoma is strongly associated with male reproductive problems commonly associated with the alteration of sperm parameters as described in testicular dysgenesis syndrome. Interestingly, numerous studies have reported that the precursor of germ cell can...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194738/ https://www.ncbi.nlm.nih.gov/pubmed/30340650 http://dx.doi.org/10.1186/s13148-018-0559-z |
_version_ | 1783364287473909760 |
---|---|
author | Bruno, Céline Blagoskonov, Oxana Barberet, Julie Guilleman, Magali Daniel, Sandrine Tournier, Benjamin Binquet, Christine Choux, Cécile Fauque, Patricia |
author_facet | Bruno, Céline Blagoskonov, Oxana Barberet, Julie Guilleman, Magali Daniel, Sandrine Tournier, Benjamin Binquet, Christine Choux, Cécile Fauque, Patricia |
author_sort | Bruno, Céline |
collection | PubMed |
description | BACKGROUND: Testicular germ cell tumor such as seminoma is strongly associated with male reproductive problems commonly associated with the alteration of sperm parameters as described in testicular dysgenesis syndrome. Interestingly, numerous studies have reported that the precursor of germ cell cancer, germ cell neoplasia in situ (GCNIS), present similarities to fetal gonocytes, specifically characterized by global DNA hypomethylation particularly on imprinting sequences. These disorders may have a common origin derived from perturbations of embryonal programming during fetal development. Presently, there is no available information concerning the sperm DNA methylation patterns of testicular cancer patients. For the first time, we evaluated the sperm imprinting of seminoma patients. A total of 92 cryopreserved sperm samples were included, 31 before seminoma treatment (S): 23 normozoospermic (SN) and 8 oligozoospermic (SO) and 61 sperm controls samples: 31 normozoospermic (N) and 30 oligozoospermic (O). DNA methylation levels of seven differentially methylated regions (DMRs) of imprinted genes [H19/IGF2: IG-DMR (CTCF3 and CTCF6 of H19 gene); IGF2-DMRs (DMR0 and DMR2); MEG3/DLK1:IG-DMR; SNURF:TSS-DMR; KCNQ1OT1:TSS-DMR] were assessed by pyrosequencing. All comparative analyses were adjusted for age. RESULTS: Comparisons of sperm DNA methylation levels between seminoma (S) and normozoospermic (N) samples showed a significant difference for the SNURF sequence (p = 0.017), but after taking into account the sperm parameters, no difference was observed. However, we confirmed a significant association between oligozoospermia (O) and imprinting defects for H19/IGF2-CTCF6 (p = 0.001), MEG3/DLK1 (p = 0.017), IGF2-DMR2 (p = 0.022), and SNURF (p = 0.032) in comparison with control groups (N). CONCLUSIONS: This study highlights the high risk of sperm imprinting defects in cases of oligozoospermia and shows for the first time that seminoma patients with normal spermatogenesis present sperm imprinting integrity. These data suggest a low probability of the involvement of a common imprinting defect in fetal cells leading to both TGCT and subfertility. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-018-0559-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6194738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61947382018-10-30 Sperm imprinting integrity in seminoma patients? Bruno, Céline Blagoskonov, Oxana Barberet, Julie Guilleman, Magali Daniel, Sandrine Tournier, Benjamin Binquet, Christine Choux, Cécile Fauque, Patricia Clin Epigenetics Research BACKGROUND: Testicular germ cell tumor such as seminoma is strongly associated with male reproductive problems commonly associated with the alteration of sperm parameters as described in testicular dysgenesis syndrome. Interestingly, numerous studies have reported that the precursor of germ cell cancer, germ cell neoplasia in situ (GCNIS), present similarities to fetal gonocytes, specifically characterized by global DNA hypomethylation particularly on imprinting sequences. These disorders may have a common origin derived from perturbations of embryonal programming during fetal development. Presently, there is no available information concerning the sperm DNA methylation patterns of testicular cancer patients. For the first time, we evaluated the sperm imprinting of seminoma patients. A total of 92 cryopreserved sperm samples were included, 31 before seminoma treatment (S): 23 normozoospermic (SN) and 8 oligozoospermic (SO) and 61 sperm controls samples: 31 normozoospermic (N) and 30 oligozoospermic (O). DNA methylation levels of seven differentially methylated regions (DMRs) of imprinted genes [H19/IGF2: IG-DMR (CTCF3 and CTCF6 of H19 gene); IGF2-DMRs (DMR0 and DMR2); MEG3/DLK1:IG-DMR; SNURF:TSS-DMR; KCNQ1OT1:TSS-DMR] were assessed by pyrosequencing. All comparative analyses were adjusted for age. RESULTS: Comparisons of sperm DNA methylation levels between seminoma (S) and normozoospermic (N) samples showed a significant difference for the SNURF sequence (p = 0.017), but after taking into account the sperm parameters, no difference was observed. However, we confirmed a significant association between oligozoospermia (O) and imprinting defects for H19/IGF2-CTCF6 (p = 0.001), MEG3/DLK1 (p = 0.017), IGF2-DMR2 (p = 0.022), and SNURF (p = 0.032) in comparison with control groups (N). CONCLUSIONS: This study highlights the high risk of sperm imprinting defects in cases of oligozoospermia and shows for the first time that seminoma patients with normal spermatogenesis present sperm imprinting integrity. These data suggest a low probability of the involvement of a common imprinting defect in fetal cells leading to both TGCT and subfertility. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-018-0559-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-19 /pmc/articles/PMC6194738/ /pubmed/30340650 http://dx.doi.org/10.1186/s13148-018-0559-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Bruno, Céline Blagoskonov, Oxana Barberet, Julie Guilleman, Magali Daniel, Sandrine Tournier, Benjamin Binquet, Christine Choux, Cécile Fauque, Patricia Sperm imprinting integrity in seminoma patients? |
title | Sperm imprinting integrity in seminoma patients? |
title_full | Sperm imprinting integrity in seminoma patients? |
title_fullStr | Sperm imprinting integrity in seminoma patients? |
title_full_unstemmed | Sperm imprinting integrity in seminoma patients? |
title_short | Sperm imprinting integrity in seminoma patients? |
title_sort | sperm imprinting integrity in seminoma patients? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194738/ https://www.ncbi.nlm.nih.gov/pubmed/30340650 http://dx.doi.org/10.1186/s13148-018-0559-z |
work_keys_str_mv | AT brunoceline spermimprintingintegrityinseminomapatients AT blagoskonovoxana spermimprintingintegrityinseminomapatients AT barberetjulie spermimprintingintegrityinseminomapatients AT guillemanmagali spermimprintingintegrityinseminomapatients AT danielsandrine spermimprintingintegrityinseminomapatients AT tournierbenjamin spermimprintingintegrityinseminomapatients AT binquetchristine spermimprintingintegrityinseminomapatients AT chouxcecile spermimprintingintegrityinseminomapatients AT fauquepatricia spermimprintingintegrityinseminomapatients |